Form 4: Chemours Director Erin Kane Acquires 7,182 Stock Units

Chemours Company Director Erin N. Kane acquired 7,182 stock units as part of board compensation.

Summary

• Director Erin N. Kane was granted 7,182 stock units on May 6, 2026.
• These units are part of board compensation and will convert one-for-one to common stock upon separation from the Board.
• Following this transaction, the director's total beneficial ownership increased to 74,062.9086 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation with no impact on company operations or financial strategy.

Positives

• Director alignment with shareholder interests through increased equity holdings.
• Standard equity-based compensation structure for board members.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The stock units are deferred and will convert to common stock upon the director's separation from the Board.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director compensation, common among S&P 500 companies to ensure board members maintain a vested interest in long-term corporate performance.

Comparison to Industry Standards

• The grant of deferred stock units is a standard practice for non-employee directors in the chemical manufacturing sector.
• The transaction aligns with typical corporate governance policies for equity-based director compensation.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard component of director compensation packages.

Next Steps

• No further actions required; the units will convert upon the director's future departure from the Board.

Key Dates

Keywords

Chemours, CC, Insider Trading, Form 4, Director Compensation, Equity Grant